India seeks US intervention in Ranbaxy fraud trial
This article was originally published in Scrip
Executive Summary
India is seeking the intervention of the US government in theRanbaxy case, where the company is being investigated for submitting allegedly fabricated data for its generics to theFDA, among other charges.
You may also be interested in...
APAC Cancer Preparedness Varied, Late Diagnosis A Key Challenge
A new report on the preparedness of 10 APAC nations to tackle a mounting cancer burden identifies gaps that need to be addressed, saying that a focus on prevention and early diagnosis could help, while also touching on issues around regional drug availability.
Asia Deal Watch: Cipla’s Latest Diabetes Partner In India Is Boehringer Ingelheim
Also, deals involving Sumitomo Dainippon, Tolero, Boston Biomedical, Zai Lab, Turning Point, SciClone, EpicentRx, Yuhan, GI Innovation, Takeda, Carmine, HitGen, Morphic, CStone and Burning Rock.
Opdivo Secures India Patent, Fends Off Multi-Party Opposition
India clears Opdivo patent, turning down pre-grant representations from four opposing parties including Dr Reddy's. The patent office rejected the opponents' arguments including those around obviousness and "inherent anticipation."
Need a specific report? 1000+ reports available
Buy Reports